Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.7 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |